Back to Search
Start Over
Substituted dienes prepared from betulinic acid – Synthesis, cytotoxicity, mechanism of action, and pharmacological parameters.
- Source :
-
European Journal of Medicinal Chemistry . Nov2021, Vol. 224, pN.PAG-N.PAG. 1p. - Publication Year :
- 2021
-
Abstract
- A set of new substituted dienes were synthesized from betulinic acid by its oxidation to 30-oxobetulinic acid followed by the Wittig reaction. Cytotoxicity of all compounds was tested in vitro in eight cancer cell lines and two noncancer fibroblasts. Almost all dienes were more cytotoxic than betulinic acid. Compounds 4.22 , 4.30 , 4.33 , 4.39 had IC 50 below 5 μmol/L; 4.22 and 4.39 were selected for studies of the mechanism of action. Cell cycle analysis revealed an increase in the number of apoptotic cells at 5 × IC 50 concentration, where activation of irreversible changes leading to cell death can be expected. Both 4.22 and 4.39 led to the accumulation of cells in the G0/G1 phase with partial inhibition of DNA/RNA synthesis at 1 × IC 50 and almost complete inhibition at 5 × IC 50. Interestingly, compound 4.39 at 5 × IC 50 caused the accumulation of cells in the S phase. Higher concentrations of tested drugs probably inhibit more off-targets than lower concentrations. Mechanisms disrupting cellular metabolism can induce the accumulation of cells in the S phase. Both compounds 4.22 and 4.39 trigger selective apoptosis in cancer cells via intrinsic pathway, which we have demonstrated by changes in the expression of the crucial apoptosis-related protein. Pharmacological parameters of derivative 4.22 were superior to 4.39 , therefore 4.22 was the finally selected candidate for the development of anticancer drug. [Display omitted] • Forty new triterpenoids were prepared from 30-oxobetulinic acid by Wittig reaction • Four compounds had high selective cytotoxicity to cancer cells • Compounds 4.22 and 4.39 were selected for further development • Both compounds cause selective apoptosis in cancer cells via the intrinsic pathway • Diene 4.22 has appropriate pharmacological parameters and will be further developed [ABSTRACT FROM AUTHOR]
- Subjects :
- *BETULINIC acid
*WITTIG reaction
*DIOLEFINS
*CELL death
*CELL cycle
*CANCER cells
Subjects
Details
- Language :
- English
- ISSN :
- 02235234
- Volume :
- 224
- Database :
- Academic Search Index
- Journal :
- European Journal of Medicinal Chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 152848188
- Full Text :
- https://doi.org/10.1016/j.ejmech.2021.113706